Characterization of a cluster of oncogenic mutations in E6 of a human papillomavirus 83 variant isolated from a high-grade squamous intraepithelial lesion

Journal of General Virology

Volumn 92, Issue 10, 2011, Pages 2428-2436

  Cannavo, Isabelle ^a,b,c   Benchetrit, Maxime ^a,b   Loubatier, Céline ^b,c   Miche, Gregory ^c   Lemichez, Emmanuel ^c   Giordanengo, Valérie ^a,b,c  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^b UNIVERSITÉ CÔTE D'AZUR   (France)

^c CENTRE MÉDITERRANÉEN DE MÉDECINE MOLÉCULAIRE C3M   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MUTANT PROTEIN; PROTEIN E6; PROTEIN P53; TELOMERASE; ZINC FINGER PROTEIN;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 83; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; UTERINE CERVIX CARCINOMA IN SITU; VIRUS CARCINOGENESIS; VIRUS ISOLATION; VIRUS MUTANT; VIRUS MUTATION; WART VIRUS;

CELL PROLIFERATION; CELLS, CULTURED; CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA, VIRAL; EPITHELIAL CELLS; HUMANS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; POINT MUTATION; PROTEIN STRUCTURE, TERTIARY; SEQUENCE ANALYSIS, DNA; ZINC FINGERS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS - 83;

EID: 80052926162     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.032888-0     Document Type: Article

References (61)

1. Albrecht, V., Chevallier, A., Bongain, A., Lefebvre, J. C. & Giordanengo, V. (2007). Immunohistochemical and molecular study of severe cervical dysplasia associated with HPV-83. Gynecol Oncol 105, 252-255.
2. Asadurian, Y., Kurilin, H., Lichtig, H., Jackman, A., Gonen, P., Tommasino, M., Zehbe, I. & Sherman, L. (2007). Activities of human papillomavirus 16 E6 natural variants in human keratinocytes. J Med Virol 79, 1751-1760.
3. Brimer, N., Lyons, C. & Vande Pol, S. B. (2007). Association of E6AP (UBE3A) with human papillomavirus type 11 E6 protein. Virology 358, 303-310.
4. Brown, D. R., McClowry, T. L., Woods, K. & Fife, K. H. (1999). Nucleotide sequence and characterization of human papillomavirus type 83, a novel genital papillomavirus. Virology 260, 165-172.
5. Brown, D. R., Legge, D. & Qadadri, B. (2002). Distribution of human papillomavirus types in cervicovaginal washings from women evaluated in a sexually transmitted diseases clinic. Sex Transm Dis 29, 763-768.
6. Cajero-Juárez, M., Avila, B., Ochoa, A., Garrido-Guerrero, E., Varela-Echavarría, A., Martínez de la Escalera, G. Clapp, C. (2002). Immortalization of bovine umbilical vein endothelial cells: a model for the study of vascular endothelium. Eur J Cell Biol 81, 1-8.
7. Capra, G., Giovannelli, L., Bellavia, C., Migliore, M. C., Caleca, M. P., Perino, A. & Ammatuna, P. (2008). HPV genotype prevalence in cytologically abnormal cervical samples from women living in south Italy. Virus Res 133, 195-200.
8. Charneau, P., Alizon, M. & Clavel, F. (1992). A second origin of DNA plus-strand synthesis is required for optimal human immunodeficiency virus replication. J Virol 66, 2814-2820.
9. Clavel, F. & Charneau, P. (1994). Fusion from without directed by human immunodeficiency virus particles. J Virol 68, 1179-1185.
10. Clere, N., Bermont, L., Fauconnet, S., Lascombe, I., Saunier, M., Vettoretti, L., Plissonnier, M. L. & Mougin, C. (2007). The human papillomavirus type 18 E6 oncoprotein induces Vascular Endothelial Growth Factor 121 (VEGF121) transcription from the promoter through a p53-independent mechanism. Exp Cell Res 313, 3239-3250.
11. Crook, T., Tidy, J. A. & Vousden, K. H. (1991). Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation. Cell 67, 547-556.
12. Da Costa, M.M., Hogeboom, C. J., Holly, E. A. & Palefsky, J. M. (2002). Increased risk of high-grade anal neoplasia associated with a human papillomavirus type 16 E6 sequence variant. J Infect Dis 185, 1229-1237.
13. de Cremoux, P., de la Rochefordiére, A., Savignoni, A., Kirova, Y., Alran, S., Fourchotte, V., Plancher, C., Thioux, M., Salmon, R. J. & other authors (2009). Different outcome of invasive cervical cancer associated with high-risk versus intermediate-risk HPV genotype. Int J Cancer 124, 778-782.
14. Desaintes, C., Hallez, S., Van Alphen, P. & Burny, A. (1992). Transcriptional activation of several heterologous promoters by the E6 protein of human papillomavirus type 16. J Virol 66, 325-333.
15. deVilliers, E.M., Fauquet, C., Broker, T.R., Bernard, H. U. & Zur Hausen, H. (2004). Classification of papillomaviruses. Virology 324, 17-27.
16. Du, M., Fan, X., Hong, E. & Chen, J. J. (2002). Interaction of oncogenic papillomavirus E6 proteins with fibulin-1. Biochem Biophys Res Commun 296, 962-969.
17. Ducrest, A. L., Szutorisz, H., Lingner, J. & Nabholz, M. (2002). Regulation of the human telomerase reverse transcriptase gene. Oncogene 21, 541-552.
18. Duffy, C. L., Phillips, S. L. & Klingelhutz, A. J. (2003). Microarray analysis identifies differentiation-associated genes regulated by human papillomavirus type 16 E6. Virology 314, 196-205.
19. Filippova, M., Song, H., Connolly, J. L., Dermody, T. S. & Duerksen- Hughes, P. J. (2002). The human papillomavirus 16 E6 protein binds to tumor necrosis factor (TNF) R1 and protects cells from TNFinduced apoptosis. J Biol Chem 277, 21730-21739.
20. Gewin, L., Myers, H., Kiyono, T. & Galloway, D. A. (2004). Identification of a novel telomerase repressor that interacts with the human papillomavirus type-16 E6/E6-AP complex. Genes Dev 18, 2269-2282.
21. Grodzki, M., Besson, G., Clavel, C., Arslan, A., Franceschi, S., Birembaut, P., Tommasino, M. & Zehbe, I. (2006). Increased risk for cervical disease progression of French women infected with the human papillomavirus type 16 E6-350G variant. Cancer Epidemiol Biomarkers Prev 15, 820-822.
22. Hawley-Nelson, P., Vousden, K. H., Hubbert, N. L., Lowy, D. R. & Schiller, J. T. (1989). HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes. EMBO J 8, 3905-3910.
23. Horikawa, I. & Barrett, J. C. (2003). Transcriptional regulation of the telomerase hTERT gene as a target for cellular and viral oncogenic mechanisms. Carcinogenesis 24, 1167-1176.
24. Howley, P. M., Münger, K., Werness, B. A., Phelps, W. C. & Schlegel, R. (1989). Molecular mechanisms of transformation by the human papillomaviruses. Princess Takamatsu Symp 20, 199-206.
25. Huibregtse, J. M., Scheffner, M. & Howley, P. M. (1991). A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18. EMBO J 10, 4129-4135.
26. Katzenellenbogen, R. A., Egelkrout, E. M., Vliet-Gregg, P., Gewin, L. C., Gafken, P. R. & Galloway, D. A. (2007). NFX1-123 and poly(A) binding proteins synergistically augment activation of telomerase in human papillomavirus type 16 E6-expressing cells. J Virol 81, 3786-3796.
27. Katzenellenbogen, R. A., Vliet-Gregg, P., Xu, M. & Galloway, D. A. (2009). NFX1-123 increases hTERT expression and telomerase activity posttranscriptionally in human papillomavirus type 16 E6 keratinocytes. J Virol 83, 6446-6456.
28. Li, X. & Coffino, P. (1996). High-risk human papillomavirus E6 protein has two distinct binding sites within p53, of which only one determines degradation. J Virol 70, 4509-4516.
29. Liu, Y., Chen, J. J., Gao, Q., Dalal, S., Hong, Y., Mansur, C. P., Band, V. & Androphy, E. J. (1999). Multiple functions of human papillomavirus type 16 E6 contribute to the immortalization of mammary epithelial cells. J Virol 73, 7297-7307.
30. Liu, X., Yuan, H., Fu, B., Disbrow, G. L., Apolinario, T., Tomaic, V., Kelley, M. L., Baker, C. C., Huibregtse, J. & Schlegel, R. (2005). The E6AP ubiquitin ligase is required for transactivation of the hTERT promoter by the human papillomavirus E6 oncoprotein. J Biol Chem 280, 10807-10816.
31. Liu, X., Dakic, A., Chen, R., Disbrow, G. L., Zhang, Y., Dai, Y. & Schlegel, R. (2008). Cell-restricted immortalization by human papillomavirus correlates with telomerase activation and engagement of the hTERT promoter by Myc. J Virol 82, 11568-11576.
32. Liu, X., Dakic, A., Zhang, Y., Dai, Y., Chen, R. & Schlegel, R. (2009). HPV E6 protein interacts physically and functionally with the cellular telomerase complex. Proc Natl Acad Sci U S A 106, 18780-18785.
33. López-Ocejo, O., Viloria-Petit, A., Bequet-Romero, M., Mukhopadhyay, D., Rak, J. & Kerbel, R. S. (2000). Oncogenes and tumor angiogenesis: the HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner. Oncogene 19, 4611-4620.
34. Mantovani, F. & Banks, L. (2001). The human papillomavirus E6 protein and its contribution to malignant progression. Oncogene 20, 7874-7887.
35. McLaughlin-Drubin, M. E. & Münger, K. (2009). Oncogenic activities of human papillomaviruses. Virus Res 143, 195-208.
36. Menzo, S., Ciavattini, A., Bagnarelli, P., Marinelli, K., Sisti, S. & Clementi, M. (2008). Molecular epidemiology and pathogenic potential of underdiagnosed human papillomavirus types. BMC Microbiol 8, 112.
37. Miller, A. D. & Rosman, G. J. (1989). Improved retroviral vectors for gene transfer and expression. Biotechniques 7, 980-982, 984-986, 989-990.
38. Moody, C. A. & Laimins, L. A. (2010). Human papillomavirus oncoproteins: pathways to transformation. Nat Rev Cancer 10, 550-560.
39. Münger, K., Phelps, W. C., Bubb, V., Howley, P. M. & Schlegel, R. (1989). The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J Virol 63, 4417-4421.
40. Muñoz, N. (2000). Human papillomavirus and cancer: the epidemiological evidence. J Clin Virol 19, 1-5.
41. Muñoz, N., Bosch, F. X., de Sanjosé, S., Herrero, R., Castellsagué, X., Shah, K. V., Snijders, P. J., Meijer, C. J. & International Agency for Research on Cancer Multicenter Cervical Cancer Study Group (2003). Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348, 518-527.
42. Nakagawa, S., Watanabe, S., Yoshikawa, H., Taketani, Y., Yoshiike, K. & Kanda, T. (1995). Mutational analysis of human papillomavirus type 16 E6 protein: transforming function for human cells and degradation of p53 in vitro. Virology 212, 535-542.
43. Richard, C., Lanner, C., Naryzhny, S. N., Sherman, L., Lee, H., Lambert, P. F. & Zehbe, I. (2010). The immortalizing and transforming ability of two common human papillomavirus 16 E6 variants with different prevalences in cervical cancer. Oncogene 29, 3435-3445.
44. Ronco, L. V., Karpova, A. Y., Vidal, M. & Howley, P. M. (1998). Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity. Genes Dev 12, 2061-2072.
45. Scheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A. J. & Howley, P. M. (1990). The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63, 1129-1136.
46. Scheffner, M., Münger, K., Byrne, J. C. & Howley, P. M. (1991). The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proc Natl Acad Sci U S A 88, 5523-5527.
47. Scheffner, M., Huibregtse, J. M., Vierstra, R. D. & Howley, P. M. (1993). The HPV-16 E6 and E6-AP complex functions as a ubiquitinprotein ligase in the ubiquitination of p53. Cell 75, 495-505.
48. Schwarz, E., Freese, U. K., Gissmann, L., Mayer, W., Roggenbuck, B., Stremlau, A. & zur Hausen, H. (1985). Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 314, 111-114.
49. Sherman, L., Itzhaki, H., Jackman, A., Chen, J. J., Koval, D. & Schlegel, R. (2002). Inhibition of serum- and calcium-induced terminal differentiation of human keratinocytes by HPV 16 E6: study of the association with p53 degradation, inhibition of p53 transactivation, and binding to E6BP. Virology 292, 309-320.
50. Si-Mohamed, A., Ndjoyi-Mbiguino, A., Cuschieri, K., Onas, I. N., Colombet, I., Ozouaki, F., Goff, J. L., Cubie, H. & Bélec, L. (2005). High prevalence of high-risk oncogenic human papillomaviruses harboring atypical distribution in women of childbearing age living in Libreville, Gabon. J Med Virol 77, 430-438.
51. Storey, A., Massimi, P., Dawson, K. & Banks, L. (1995). Conditional immortalization of primary cells by human papillomavirus type 18 E6 and EJ-ras defines an E6 activity in G0/G1 phase which can be substituted for mutations in p53. Oncogene 11, 653-661.
52. Veldman, T., Horikawa, I., Barrett, J. C. & Schlegel, R. (2001). Transcriptional activation of the telomerase hTERT gene by human papillomavirus type 16 E6 oncoprotein. J Virol 75, 4467-4472.
53. Veldman, T., Liu, X., Yuan, H. & Schlegel, R. (2003). Human papillomavirus E6 and Myc proteins associate in vivo and bind to and cooperatively activate the telomerase reverse transcriptase promoter. Proc Natl Acad Sci U S A 100, 8211-8216.
54. Watanabe, S., Kanda, T. & Yoshiike, K. (1989). Human papillomavirus type 16 transformation of primary human embryonic fibroblasts requires expression of open reading frames E6 and E7. J Virol 63, 965-969.
55. Wege, H., Chui, M. S., Le, H. T., Tran, J. M. & Zern, M. A. (2003). SYBR Green real-time telomeric repeat amplification protocol for the rapid quantification of telomerase activity. Nucleic Acids Res 31, E3-E3.
56. Werness, B. A., Levine, A. J. & Howley, P. M. (1990). Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 248, 76-79.
57. Wu, Y., Chen, Y., Li, L., Yu, G., He, Y. & Zhang, Y. (2006). Analysis of mutations in the E6/E7 oncogenes and L1 gene of human papillomavirus 16 cervical cancer isolates from China. J Gen Virol 87, 1181-1188.
58. Yugawa, T. & Kiyono, T. (2009). Molecular mechanisms of cervical carcinogenesis by high-risk human papillomaviruses: novel functions of E6 and E7 oncoproteins. Rev Med Virol 19, 97-113.
59. Zehbe, I., Wilander, E., Delius, H. & Tommasino, M. (1998). Human papillomavirus 16 E6 variants are more prevalent in invasive cervical carcinoma than the prototype. Cancer Res 58, 829-833.
60. Zehbe, I., Richard, C., DeCarlo, C. A., Shai, A., Lambert, P. F., Lichtig, H., Tommasino, M. & Sherman, L. (2009). Human papillomavirus 16 E6 variants differ in their dysregulation of human keratinocyte differentiation and apoptosis. Virology 383, 69-77.
61. Zuna, R. E., Moore, W. E., Shanesmith, R. P., Dunn, S. T., Wang, S. S., Schiffman, M., Blakey, G. L. & Teel, T. (2009). Association of HPV16 E6 variants with diagnostic severity in cervical cytology samples of 354 women in a US population. Int J Cancer 125, 2609-2613.